Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

Rhea-AI Summary

Bio-Rad Laboratories (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, has announced it will report its financial results for the second quarter of 2024 on Thursday, August 1, 2024, after market close. The company will host a conference call at 2 PM Pacific Time (5 PM Eastern Time) on the same day to discuss the results. Investors can participate by dialing 800-343-4849 (U.S.) or 203-518-9856 (outside U.S.) with the access code: BIORAD. A live webcast will be available on the company's website, and a replay will be accessible for up to a year.

Positive

• Bio-Rad is maintaining transparency by scheduling a conference call to discuss Q2 2024 results
• The company offers multiple ways for investors to access the financial results discussion

Negative

• None.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2024 on Thursday, August 1, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To participate, dial 800-343-4849 within the U.S. or 203-518-9856 outside the U.S., access code: BIORAD. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240717756036/en/

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad (BIO) report its Q2 2024 financial results?

Bio-Rad Laboratories (BIO) will report its second quarter 2024 financial results on Thursday, August 1, 2024, after the market closes.

How can investors participate in Bio-Rad's (BIO) Q2 2024 earnings call?

Investors can participate in Bio-Rad's Q2 2024 earnings call by dialing 800-343-4849 (U.S.) or 203-518-9856 (outside U.S.) with the access code: BIORAD. A live webcast will also be available on the company's website.

What time is Bio-Rad's (BIO) Q2 2024 earnings conference call scheduled for?

Bio-Rad's Q2 2024 earnings conference call is scheduled for 2 PM Pacific Time (5 PM Eastern Time) on Thursday, August 1, 2024.

Where can investors find the webcast of Bio-Rad's (BIO) Q2 2024 earnings call?

The live webcast of Bio-Rad's Q2 2024 earnings call will be available in the 'Investor Relations' section of the company's website under 'Events & Presentations' at investors.bio-rad.com.